The consequences of under-use of coronary revascularization; results of a cohort study in Northern Italy

G Filardo1, A P Maggioni, G Mura

  • 1Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.

Insights

Underuse of indicated coronary artery bypass graft (CABG) or percutaneous transluminal coronary angioplasty (PTCA) significantly increases patient mortality. Ensuring access to these revascularization procedures is crucial for quality cardiac care.

Area of Science:

  • Cardiology
  • Health Services Research
  • Outcomes Research

Background:

  • Coronary revascularization procedures, including coronary artery bypass graft (CABG) and percutaneous transluminal coronary angioplasty (PTCA), are standard treatments for significant coronary artery disease.
  • Assessing the impact of under-utilization of these procedures on patient outcomes is essential for quality improvement initiatives.

Purpose of the Study:

  • To evaluate the association between the under-use of indicated coronary artery bypass graft (CABG) or percutaneous transluminal coronary angioplasty (PTCA) and patient mortality.
  • To identify potential quality of care issues related to the under-utilization of revascularization procedures.

Main Methods:

  • A prospective observational study followed 1258 patients eligible for CABG or PTCA after an index angiogram.
  • Data on patient characteristics, procedures performed, and vital status were collected from multiple sources.
  • Mortality was assessed at a minimum of 9 months follow-up, with unadjusted and adjusted analyses.

Main Results:

  • Patients who underwent CABG or PTCA (n=863) had significantly lower mortality rates (4.8%) compared to those who did not (n=350, 10.6%; P=0.001).
  • This finding remained significant after adjusting for risk factors and in survival analysis (adjusted OR=0.48, adjusted HR=0.31).

Conclusions:

  • Failure to perform indicated revascularization procedures is associated with increased patient mortality, highlighting a potential quality of care problem.
  • Limited healthcare capacity, such as waiting lists, may be a primary driver of this under-use.
  • The study supports the validity of the RAND method for assessing the impact of under-use in coronary revascularization.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...